PetMed Express Inc has a consensus price target of $3.35 based on the ratings of 2 analysts. The high is $3.5 issued by Lake Street on August 7, 2024. The low is $3.2 issued by Morgan Stanley on April 17, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Lake Street, and Lake Street on April 17, 2025, August 7, 2024, and June 12, 2024, respectively. With an average price target of $4.57 between Morgan Stanley, Lake Street, and Lake Street, there's an implied 17.09% upside for PetMed Express Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/17/2025 | Buy Now | -17.95% | Morgan Stanley | Erin Wright74% | $3.5 → $3.2 | Maintains | Underweight | Get Alert |
08/07/2024 | Buy Now | -10.26% | Lake Street | Ryan Meyers34% | $7 → $3.5 | Downgrade | Buy → Hold | Get Alert |
06/12/2024 | Buy Now | 79.49% | Lake Street | Ryan Meyers34% | $9 → $7 | Maintains | Buy | Get Alert |
06/12/2024 | Buy Now | -10.26% | Morgan Stanley | Erin Wright74% | $6.5 → $3.5 | Maintains | Underweight | Get Alert |
02/09/2024 | Buy Now | 130.77% | Lake Street | Ryan Meyers34% | $13 → $9 | Maintains | Buy | Get Alert |
11/16/2023 | Buy Now | 66.67% | Morgan Stanley | Erin Wright74% | $7 → $6.5 | Maintains | Underweight | Get Alert |
10/31/2023 | Buy Now | 79.49% | Morgan Stanley | Erin Wright74% | $10 → $7 | Maintains | Underweight | Get Alert |
10/19/2023 | Buy Now | 156.41% | Morgan Stanley | Erin Wright74% | $17 → $10 | Maintains | Underweight | Get Alert |
07/27/2023 | Buy Now | 335.9% | Morgan Stanley | Erin Wright74% | $17 → $17 | Reiterates | Underweight → Underweight | Get Alert |
05/25/2023 | Buy Now | 412.82% | Lake Street | Ryan Meyers34% | → $20 | Initiates | → Buy | Get Alert |
03/23/2023 | Buy Now | 335.9% | Morgan Stanley | Erin Wright74% | $18 → $17 | Maintains | Underweight | Get Alert |
11/08/2022 | Buy Now | 361.54% | Morgan Stanley | Erin Wright74% | $19 → $18 | Maintains | Underweight | Get Alert |
07/26/2022 | Buy Now | 387.18% | Morgan Stanley | Erin Wright74% | $20 → $19 | Maintains | Underweight | Get Alert |
The latest price target for PetMed Express (NASDAQ:PETS) was reported by Morgan Stanley on April 17, 2025. The analyst firm set a price target for $3.20 expecting PETS to fall to within 12 months (a possible -17.95% downside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for PetMed Express (NASDAQ:PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.
There is no last upgrade for PetMed Express
The last downgrade for PetMed Express Inc happened on August 7, 2024 when Lake Street changed their price target from $7 to $3.5 for PetMed Express Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on April 17, 2025 so you should expect the next rating to be made available sometime around April 17, 2026.
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $3.50 to $3.20. The current price PetMed Express (PETS) is trading at is $3.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.